A Coding-independent Function of Gene and Pseudogene MRNAs Regulates Tumour Biology

Overview

Journal Nature

Specialty Science

Date 2010 Jun 26

PMID 20577206

Citations 1278

Authors

Laura Poliseno

Leonardo Salmena

Jiangwen Zhang

Brett Carver

William J Haveman

Pier Paolo Pandolfi

Affiliations

Soon will be listed here.

Abstract

The canonical role of messenger RNA (mRNA) is to deliver protein-coding information to sites of protein synthesis. However, given that microRNAs bind to RNAs, we hypothesized that RNAs could possess a regulatory role that relies on their ability to compete for microRNA binding, independently of their protein-coding function. As a model for the protein-coding-independent role of RNAs, we describe the functional relationship between the mRNAs produced by the PTEN tumour suppressor gene and its pseudogene PTENP1 and the critical consequences of this interaction. We find that PTENP1 is biologically active as it can regulate cellular levels of PTEN and exert a growth-suppressive role. We also show that the PTENP1 locus is selectively lost in human cancer. We extended our analysis to other cancer-related genes that possess pseudogenes, such as oncogenic KRAS. We also demonstrate that the transcripts of protein-coding genes such as PTEN are biologically active. These findings attribute a novel biological role to expressed pseudogenes, as they can regulate coding gene expression, and reveal a non-coding function for mRNAs.

Citing Articles

MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer.

Zhong L, Zhu J, Chen J, Jin X, Liu L, Ji S Cancer Biol Ther. 2025; 26(1):2475604.

PMID: 40069131 PMC: 11901376. DOI: 10.1080/15384047.2025.2475604.

Diagnostics and Therapy for Malignant Tumors.

Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T Biomedicines. 2025; 12(12.

PMID: 39767566 PMC: 11726849. DOI: 10.3390/biomedicines12122659.

lncRNA SNHG4 enhanced gastric cancer progression by modulating miR-409-3p/CREB1 axis.

Cheng Z, Hua Y, Cao Y, Qin J Oncol Res. 2024; 33(1):185-198.

PMID: 39735673 PMC: 11671409. DOI: 10.32604/or.2024.042281.

Competing endogenous RNAs network dysregulation in oral cancer: a multifaceted perspective on crosstalk and competition.

Wu J, Zhang C, Li H, Zhang S, Chen J, Qin L Cancer Cell Int. 2024; 24(1):431.

PMID: 39725978 PMC: 11673722. DOI: 10.1186/s12935-024-03580-2.

Out-of-Equilibrium ceRNA Crosstalk.

Ferro E, Szischik C, Cunial M, Ventura A, De Martino A, Bosia C Methods Mol Biol. 2024; 2883:167-193.

PMID: 39702709 DOI: 10.1007/978-1-0716-4290-0_8.

References

Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I . TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol. 2009; 11(7):881-9. PMC: 2744130. DOI: 10.1038/ncb1897. View

Zhang L, Huang J, Yang N, Greshock J, Megraw M, Giannakakis A . microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006; 103(24):9136-41. PMC: 1474008. DOI: 10.1073/pnas.0508889103. View

Kim J, Bartel D . Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression. Nat Biotechnol. 2009; 27(5):472-7. PMC: 2828817. DOI: 10.1038/nbt.1540. View

Myers M, Stolarov J, Eng C, Li J, Wang S, Wigler M . P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A. 1997; 94(17):9052-7. PMC: 23024. DOI: 10.1073/pnas.94.17.9052. View

DErrico I, Gadaleta G, Saccone C . Pseudogenes in metazoa: origin and features. Brief Funct Genomic Proteomic. 2004; 3(2):157-67. DOI: 10.1093/bfgp/3.2.157. View

Mayr C, Bartel D . Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell. 2009; 138(4):673-84. PMC: 2819821. DOI: 10.1016/j.cell.2009.06.016. View

Guttman M, Amit I, Garber M, French C, Lin M, Feldser D . Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458(7235):223-7. PMC: 2754849. DOI: 10.1038/nature07672. View

Winter J, Jung S, Keller S, Gregory R, Diederichs S . Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11(3):228-34. DOI: 10.1038/ncb0309-228. View

Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko V, Rogounovitch T . Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci. 2008; 99(6):1147-54. PMC: 11160010. DOI: 10.1111/j.1349-7006.2008.00800.x. View

10.

Maeda T, Hobbs R, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C . Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005; 433(7023):278-85. DOI: 10.1038/nature03203. View

11.

Drabkin H, Parsy C, Ferguson K, Guilhot F, Lacotte L, Roy L . Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia. 2002; 16(2):186-95. DOI: 10.1038/sj.leu.2402354. View

12.

Stephens P, McBride D, Lin M, Varela I, Pleasance E, Simpson J . Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009; 462(7276):1005-10. PMC: 3398135. DOI: 10.1038/nature08645. View

13.

Fujii G, Morimoto A, Berson A, Bolen J . Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene. 1999; 18(9):1765-9. DOI: 10.1038/sj.onc.1202492. View

14.

Yang H, Kong W, He L, Zhao J, ODonnell J, Wang J . MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008; 68(2):425-33. DOI: 10.1158/0008-5472.CAN-07-2488. View

15.

Frith M, Wilming L, Forrest A, Kawaji H, Tan S, Wahlestedt C . Pseudo-messenger RNA: phantoms of the transcriptome. PLoS Genet. 2006; 2(4):e23. PMC: 1449882. DOI: 10.1371/journal.pgen.0020023. View

16.

Ventura A, Jacks T . MicroRNAs and cancer: short RNAs go a long way. Cell. 2009; 136(4):586-91. PMC: 3910108. DOI: 10.1016/j.cell.2009.02.005. View

17.

Trotman L, Niki M, Dotan Z, Koutcher J, Di Cristofano A, Xiao A . Pten dose dictates cancer progression in the prostate. PLoS Biol. 2003; 1(3):E59. PMC: 270016. DOI: 10.1371/journal.pbio.0000059. View

18.

Birney E, Stamatoyannopoulos J, Dutta A, Guigo R, Gingeras T, Margulies E . Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007; 447(7146):799-816. PMC: 2212820. DOI: 10.1038/nature05874. View

19.

Xiao C, Srinivasan L, Calado D, Patterson H, Zhang B, Wang J . Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008; 9(4):405-14. PMC: 2533767. DOI: 10.1038/ni1575. View

20.

Suo G, Han J, Wang X, Zhang J, Zhao Y, Zhao Y . Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun. 2005; 337(4):1047-51. DOI: 10.1016/j.bbrc.2005.09.157. View